Pharmaceuticals

Dukoral Market Forecast With Insights On Demand And Industry Growth

May 5, 2026May 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Dukoral Market From 2026 To 2030?

In the past, the observed growth was driven by factors such as cholera outbreaks occurring in regions where the disease is prevalent, an increase in global travel, official government recommendations for vaccinations, the longstanding presence of waterborne illnesses, and the establishment of more travel health clinics.

The anticipated expansion during the forecast period can be linked to a rise in global travel, the spread of cholera influenced by climate change, increased spending on preventive healthcare, innovations in oral vaccine formulations, and a greater emphasis on traveler health safety. Significant developments expected in the forecast timeframe include the widening adoption of oral vaccines, an increase in travel health immunizations, a heightened focus on preventing enteric diseases, a preference for non-injectable vaccines, and growing awareness regarding the risks of cholera and ETEC.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20040&type=smp

What Major Factors Are Driving The Dukoral Market Forward?

The increasing occurrence of cholera cases is anticipated to propel the expansion of the dukoral market. Cholera, an acute diarrheal illness resulting from consuming food or water tainted with Vibrio cholerae, can lead to critical dehydration and, in severe instances, death. The surge in cholera is exacerbated by inadequate sanitation, impure water, and climate change, creating favorable conditions for its spread. Dukoral, an oral cholera vaccine, aids in reducing cholera infections by building immunity against the Vibrio cholerae bacteria and its toxin, thereby lowering the chances of contracting the disease. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental body, reported in September 2024 that cholera cases rose by 13% in 2023, alongside a notable 71% increase in deaths compared to 2022, amounting to over 4,000 fatalities from a disease that is both preventable and treatable. Consequently, the growing incidence of cholera cases is expected to stimulate the growth of the dukoral market.

How Is The Dukoral Market Broken Down By Segment Categories?

The dukoral market covered in this report is segmented –

1) By Indication: Cholera, Traveler’s Diarrhea

2) By Distribution Channel: Pharmacies, Travel Clinics, Healthcare Providers

3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

What Trends Are Influencing The Dukoral Market?

Major companies operating in the dukoral market are prioritizing innovation in vaccine formulations, particularly low-cost oral cholera vaccines, to enhance vaccine efficacy and simplify their administration. These affordable, easy-to-administer vaccines, taken by mouth, are specifically designed to protect against cholera and offer enhanced accessibility, particularly in resource-limited and outbreak-prone regions. For instance, in April 2023, the International Vaccine Institute (IVI), a South Korea-based non-profit, autonomous international organization, partnered with the University of Gothenburg, a Sweden-based institution, to develop DuoChol, a low-cost oral cholera vaccine (OCV). This collaboration aims to advance DuoChol, which features a dry formulation consisting of inactivated bacterial whole cells and the cholera toxin B subunit in capsule form. It has a similar composition to DUKORAL but offers improved thermostability, indicating stability at higher temperatures, along with reduced weight and volume. The Phase I clinical trial for DuoChol will take place in Sweden, funded by the Wellcome Trust and the Swedish government.

Which Players Are Present In The Dukoral Market Space?

Major companies operating in the dukoral market are Valneva SE

Get The Full Dukoral Market Report:

https://www.thebusinessresearchcompany.com/report/dukoral-global-market-report

Which Region Is The Leading Market For The Dukoral Market?

Asia-Pacific was the largest region in the dukoral market in 2025. The regions covered in the dukoral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Dukoral Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/dukoral-global-market-report

Browse Through More Reports Similar to the Global Dukoral Market 2026, By The Business Research Company

Direct Selling Market Report 2026

https://www.thebusinessresearchcompany.com/report/direct-selling-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Inductor Market Market Report 2026

https://www.thebusinessresearchcompany.com/report/inductor-market-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795